These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 4897422

  • 1. [When are vasodilator agents effective in arterial occlusive diseases? Plethysmographic measurements in a double blind trial].
    Baitsch G, Schäfer M.
    Med Welt; 1969 Aug 30; 35():1910-3. PubMed ID: 4897422
    [No Abstract] [Full Text] [Related]

  • 2. [Venous occlusive plethysmography as physical measuring procedure in arterial occlusive diseases, its significance for angiological diagnosis and methodical problems].
    Enger H.
    Z Gesamte Inn Med; 1969 Aug 01; 24(15):472-7. PubMed ID: 5363186
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical trial of fenoxedil in peripheral artery diseases].
    Warembourg H, Thery C.
    Lille Med; 1976 Jan 01; 21(1 suppl 1):4-7. PubMed ID: 1256230
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of an intra-arterially infused vasodilator (ATP) on the calf blood supply in dependence on dosage and severity of the blood circulation disorder].
    Grüntzig A, Bollinger A.
    Dtsch Med Wochenschr; 1971 Aug 27; 96(35):1383-6. PubMed ID: 5565966
    [No Abstract] [Full Text] [Related]

  • 6. [The effect of Vasculat on the peripheral blood circulation and the economy of circulatory function].
    Herrwerth E, Brenner L.
    Med Klin; 1966 Dec 09; 61(49):1969-71. PubMed ID: 5339977
    [No Abstract] [Full Text] [Related]

  • 7. Medical therapy in arterial disorders of the extremities: Vasodilator drugs.
    Myers KA.
    Mod Treat; 1967 Mar 09; 4(2):370-85. PubMed ID: 5341885
    [No Abstract] [Full Text] [Related]

  • 8. [Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Lehrach F, Müller R.
    Arzneimittelforschung; 1971 Aug 09; 21(8):1171-4. PubMed ID: 5110012
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK.
    Med Welt; 1973 Sep 28; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract] [Full Text] [Related]

  • 13. [Relationship between blood flow values of the upper and the lower extremities and effects of a vasoactive agent in persons with normal circulation and patients with vascular diseases].
    Caesar K.
    Med Welt; 1971 Apr 03; 14():559-62. PubMed ID: 5551942
    [No Abstract] [Full Text] [Related]

  • 14. Peripheral arterial insufficiency in ergotism. Review of the literature and foot plethysmographic studies in ergotamine poisoning.
    Iuel J, Mune O.
    Vasc Dis; 1967 Jun 03; 4(3):159-66. PubMed ID: 6028826
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The influence of vasodilator drugs on walking, in chronic occlusion of the leg arteries.
    Schlüssel H.
    Angiologica; 1966 Jun 03; 3(6):370-6. PubMed ID: 5958239
    [No Abstract] [Full Text] [Related]

  • 17. Isoxsuprine as an oral vasodilator.
    Zsotér TT, Baird RJ.
    Can Med Assoc J; 1974 Jun 08; 110(11):1260-1. PubMed ID: 4599483
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.